Carregant...
Progression-free survival as a surrogate endpoint in advanced breast cancer
OBJECTIVES: Progression-free survival (PFS) has not been validated as a surrogate endpoint for overall survival (OS) for anthracycline (A) and taxane-based (T) chemotherapy in advanced breast cancer (ABC). Using trial-level, meta-analytic approaches, we evaluated PFS as a surrogate endpoint. METHODS...
Guardat en:
| Publicat a: | Int J Technol Assess Health Care |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744081/ https://ncbi.nlm.nih.gov/pubmed/18828930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S0266462308080495 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|